甲状腺乳头状微小癌中央区淋巴结转移的预测因素

武元元; 王军; 刘勤江

doi:10.13201/j.issn.2096-7993.2020.10.022

甲状腺乳头状微小癌中央区淋巴结转移的预测因素

- 甘肃省肿瘤医院头颈外科甘肃省头颈肿瘤外科临床医学中心(兰州，730050)
基金项目:
甘肃省卫生行业科研计划项目(No：GSWSKY2018-05)；陇原青年创新创业人才项目〔甘组通字(2019)39号〕

详细信息

通讯作者: 王军，E-mail：Jack3376@126.com

^Δ审校者

中图分类号: R736.1

收稿日期: 2019-09-02

刊出日期: 2020-10-05

Predictors for central lymph node metastases in papillary thyroid microcarcinoma

More Information

Corresponding author: WANG Jun, E-mail: Jack3376@126.com

Received Date: 02 September 2019

Publish Date: 05 October 2020

摘要

- 甲状腺乳头状微小癌 /
- 淋巴结转移 /
- 危险因素
Abstract: In recent years, with the wide application of ultrasound in health examination, the incidence of papillary thyroid microcarcinoma(PTMC) is increasing rapidly. There is more controversy about whether prophylactic central lymph node dissection(PCND) should be performed in PTMC patients with clinical lymph node negative(cN0). Some clinical and pathological factors were associated with central lymph node metastasis in patients with PTMC. This paper review the risk factors for predicting central lymph node metastasis so as to screen high-risk PTMC patients who need to receive PCND, and guide clinicians to choose reasonable individualized surgery.
- papillary thyroid microcarcinoma /
- lymph node metastasis /
- risk factors

HTML全文

参考文献(27)

[1]	Wu X, Li BL, Zheng CJ, et al. Predictive factors for central lymph node metastases in papillary thyroid microcarcinoma[J]. World J Clin Cases, 2020, 8(8): 1350-1360. doi: 10.12998/wjcc.v8.i8.1350
[2]	Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J]. Thyroid, 2016, 26(1): 1-133. doi: 10.1089/thy.2015.0020
[3]	Gao M, Ge M, Ji Q, et al. 2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma[J]. Cancer Biol Med, 2017, 14(3): 203-211. doi: 10.20892/j.issn.2095-3941.2017.0051
[4]	Oh HS, Park S, Kim M, et al. Young age and male sex can are predictors of large-volume central neck lymph node metastasis in clinical N0 papillary thyroid microcarcinomas[J]. Thyroid, 2017, 27(10): 1285-1290. doi: 10.1089/thy.2017.0250
[5]	Zhang Q, Wang Z, Meng X, et al. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma(mPTC): A retrospect analysis of 1304 cases[J]. Asian J Surg, 2019, 42(4): 571-576. doi: 10.1016/j.asjsur.2018.08.013
[6]	Gui CY, Qiu SL, Peng ZH, et al. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study[J]. J Endocrinol Invest, 2018, 41(4): 403-409. doi: 10.1007/s40618-017-0759-y
[7]	沈文亮, 黑虎, 龚文博, 等. 甲状腺微小乳头状癌中央区淋巴结转移相关因素分析[J]. 中华内分泌外科杂志, 2018, 12(1): 30-33. doi: 10.3760/cma.j.issn.1674-6090.2018.01.008
[8]	Li M, Zhu XY, Lv J, et al. Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma(CN0): a study of 273 resections[J]. Eur Rev Med Pharmacol Sci, 2017, 21(17): 3801-3807.
[9]	Yuan J, Li J, Chen X, et al. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma[J]. Bull Cancer, 2017, 104(6): 516-523. doi: 10.1016/j.bulcan.2017.03.005
[10]	Liu Z, Wang L, Yi P, et al. Risk factors for central lymph node metastasis of patients with papillary thyroid microcarcinoma: a meta-analysis[J]. Int J Clin Exp Pathol, 2014, 7(3): 932-937.
[11]	Qu N, Zhang L, Ji QH, et al. Risk factors for central compartment lymph node metastasis in papillary thyroid microcarcinoma: a meta-analysis[J]. World J Surg, 2015, 39(10): 2459-2470. doi: 10.1007/s00268-015-3108-3
[12]	武元元, 刘锐锋, 范向达, 等. cN0期甲状腺乳头状微小癌中央区淋巴结转移危险因素的Meta分析[J]. 中国医学文摘耳鼻咽喉科学, 2020, 35(1): 4-9. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYEB202001002.htm
[13]	Xu Y, Xu L, Wang J, et al. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution[J]. J Surg Res, 2018, 221: 128-134. doi: 10.1016/j.jss.2017.08.007
[14]	李晓京, 杨乐, 马斌林. 1988例甲状腺微小乳头状癌颈部中央区淋巴结转移危险因素分析[J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(1): 52-57. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201701015.htm
[15]	Li F, Wu Y, Chen L, et al. Evaluation of clinical risk factors for predicting insidious right central and posterior right recurrent laryngeal nerve lymph node metastasis in papillary thyroid microcarcinoma patients(cN0): experience of a single center[J]. Ann Transl Med, 2019, 7(1): 8. doi: 10.21037/atm.2018.12.43
[16]	Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation[J]. Thyroid, 2014, 24(1): 27-34. doi: 10.1089/thy.2013.0367
[17]	Zheng XQ, Peng C, Gao M, et al. Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1587 patients[J]. Cancer Biol Med, 2019, 16(1): 121-130. doi: 10.20892/j.issn.2095-3941.2018.0125
[18]	Lee KJ, Cho YJ, Kim SJ, et al. Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size[J]. World J Surg, 2011, 35(2): 318-323. doi: 10.1007/s00268-010-0886-5
[19]	徐雅男, 王家东. 甲状腺乳头状微小癌淋巴结转移相关因素分析[J]. 临床耳鼻咽喉头颈外科杂志, 2007, 21(15): 679-682. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH200715004.htm
[20]	王朝晖, 张悦嘉, 伏桂明, 等. 甲状腺微小乳头状癌中央区淋巴转移的危险因素分析[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(1): 12-17. https://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL202105011.htm
[21]	Ozden S, Er S, Saylam B, et al. A comparison of logistic regression and artificial neural networks in predicting central lymph node metastases in papillary thyroid microcarcinoma[J]. Ann Ital Chir, 2018, 89: 193-198.
[22]	Zhang C, Li BJ, Liu Z, et al. Predicting the factors associated with central lymph node metastasis in clinical node-negative(cN0) papillary thyroid microcarcinoma[J]. Eur Arch Otorhinolaryngol, 2020, 277(4): 1191-1198. doi: 10.1007/s00405-020-05787-1
[23]	Zhao C, Jiang W, Gao Y, et al. Risk factors for lymph node metastasis(LNM)in patients with papillary thyroid microcarcinoma(PTMC): role of preoperative ultrasound[J]. J Int Med Res, 2017, 45(3): 1221-1230. doi: 10.1177/0300060517708943
[24]	Jin WX, Ye DR, Sun YH, et al. Prediction of central lymph node metastasis in papillary thyroid microcarcinoma according to clinicopathologic factors and thyroid nodule sonographic features: a case-control study[J]. Cancer Manag Res, 2018, 10: 3237-3243. doi: 10.2147/CMAR.S169741
[25]	Tao Y, Wang CJ, Li LY, et al. Clinicopathological features for predicting central and lateral lymph node metastasis in papillary thyroid microcarcinoma: Analysis of 66 cases that underwent central and lateral lymph node dissection[J]. Mol Clin Oncol, 2017, 6(1): 49-55. doi: 10.3892/mco.2016.1085
[26]	Ren HY, Shen YF, Hu DX, et al. Co-existence of BRAF ^V600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis[J]. Cancer Manag Res, 2018, 10: 1005-1013. doi: 10.2147/CMAR.S159583
[27]	Song JY, Sun SR, Dong F, et al. Predictive Value of BRAF^V600E Mutation for Lymph Node Metastasis in Papillary Thyroid Cancer: A Meta-analysis[J]. Curr Med Sci, 2018, 38(5): 785-797.